Clinical Trial

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Recruiting
View on ClinicalTrials.gov →
Summary
This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the nucleus accumbens (NAc) as adjunctive treatment for treatment-refractory opioid use disorder. This study will include 3 individuals with opioid use disorder and relapsing opioid use despite active participation in a drug addiction treatment program.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2020-04-16; most recent amendment 2026-06-17.
Status change: Not Yet Recruiting → Recruiting 2022-02-09
Trial Details
NCT Number NCT04354077
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborators: Abbott
Conditions Opioid-use Disorder
Enrollment 3 participants
Start Date 2022-02-07
Primary Completion 2029-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-18